Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Santaolalla, Aida"'
Autor:
Marsden T; Division of Surgical and Interventional Sciences, University College London, London, UK teresa.marsden@ucl.ac.uk.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Lomas DJ; Department of Urology, Mayo Clinic, Rochester, New York, USA., McCartan N; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Hadley J; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Tuck S; ReIMAGINE Consortium Patient Representative, University College London, London, UK., Brown L; MRC Clinical Trials Unit, University College London, London, UK., Haire A; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Moss CL; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Green S; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Coolen T; London Institute for Mathematical Sciences, London, UK., Santaolalla A; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK., Isaac E; Centre for Medical Imaging, University College London, London, UK., Brembilla G; Centre for Medical Imaging, University College London, London, UK., Kopcke D; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Giganti F; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Sidhu H; Centre for Medical Imaging, University College London, London, UK., Punwani S; Centre for Medical Imaging, University College London, London, UK., Emberton M; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Moore CM; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Sep 30; Vol. 11 (9), pp. e048144. Date of Electronic Publication: 2021 Sep 30.
Autor:
Beckmann, Kerri, Santaolalla, Aida, Sugimoto, Mikio, Carroll, Peter, Rubio, Jose, Villers, Arnauld, Bjartell, Anders, Morgan, Todd, Dasgupta, Prokar, Van Hemelrijck, Mieke, Elhage, Oussama, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
Publikováno v:
Prostate cancer and prostatic diseases, vol 26, iss 2
BackgroundCurrently, follow-up protocols are applied equally to men on active surveillance (AS) for prostate cancer (PCa) regardless of findings at their initial follow-up biopsy. To determine whether less intensive follow-up is suitable following ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::9c99680c86f1ed8249c4298ddae8a8e3
https://escholarship.org/uc/item/5dk12186
https://escholarship.org/uc/item/5dk12186
Autor:
Singh, Sohail, Sandhu, Preeti, Beckmann, Kerri, Santaolalla, Aida, Dewan, Kamal, Clovis, Sharon, Rusere, Jonah, Zisengwe, Grace, Challacombe, Benjamin, Brown, Christian, Cathcart, Paul, Popert, Rick, Dasgupta, Prokar, Van Hemelrijck, Mieke, Elhage, Oussama
Publikováno v:
BJU International; Jul2021, Vol. 128 Issue 1, p72-78, 7p
Autor:
Shah, Salonee, Beckmann, Kerri, Van Hemelrijck, Mieke, Challacombe, Ben, Popert, Rick, Dasgupta, Prokar, Rusere, Jonah, Zisengwe, Grace, Elhage, Oussama, Santaolalla, Aida
Publikováno v:
BMC Cancer; 5/19/2021, Vol. 21 Issue 1, p1-12, 12p
Autor:
Kerri R, Beckmann, Chris H, Bangma, Jozien, Helleman, Anders, Bjartell, Peter R, Carroll, Todd, Morgan, Daan, Nieboer, Aida, Santaolalla, Bruce J, Trock, Riccardo, Valdagni, Monique J, Roobol
Publikováno v:
Prostate, 82(7), 876-879. Wiley-Liss Inc.
2022, ' Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer : An analysis of the G.A.P.3 global consortium database ', Prostate, vol. 82, no. 7, pp. 876-879 . https://doi.org/10.1002/pros.24330
2022, ' Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer : An analysis of the G.A.P.3 global consortium database ', Prostate, vol. 82, no. 7, pp. 876-879 . https://doi.org/10.1002/pros.24330
Refereed/Peer-reviewed Background: The optimal interval for repeat biopsy during active surveillance (AS) for prostate cancer is yet to be defined. This study examined whether risk of upgrading (to grade group ≥ 2) or risk of converting to treatmen
Autor:
Kerri Beckmann, Benjamin Challacombe, Sharon Clovis, Oussama Elhage, Christian Brown, Prokar Dasgupta, Aida Santaolalla, Rick Popert, Preeti Sandhu, Paul Cathcart, Mieke Van Hemelrijck, Sohail Singh, Grace Zisengwe, Kamal Dewan, Jonah Rusere
To determine the risk of disease progression and conversion to active treatment following a negative biopsy while on active surveillance (AS) for prostate cancer (PCa).Men on an AS programme at a single tertiary hospital (London, UK) between 2003 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eb7104cd7401c6841dc2ed705b22fb5
https://hdl.handle.net/11541.2/144947
https://hdl.handle.net/11541.2/144947